Alaunos Therapeutics, Inc. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Alaunos Therapeutics, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2010 to 2023.
  • Alaunos Therapeutics, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $0.000.
  • Alaunos Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was -$18.1M, a 385% decline from 2022.
  • Alaunos Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $6.37M, a 75.3% decline from 2021.
  • Alaunos Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $25.8M, a 74.8% decline from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$18.1M -$24.5M -385% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-01
2022 $6.37M -$19.4M -75.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-01
2021 $25.8M -$76.3M -74.8% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-07
2020 $102M +$43M +72.6% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-30
2019 $59.2M +$18.8M +46.7% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-01
2018 $40.3M -$4.99M -11% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-01
2017 $45.3M +$46.1M Jan 1, 2017 Dec 31, 2017 10-K 2020-03-02
2016 -$788K Jan 1, 2016 Dec 31, 2016 10-K 2019-03-05
2013 $54.5M +$5.55M +11.3% Jan 1, 2013 Dec 31, 2013 10-K 2014-03-03
2012 $49M -$35.3M -41.9% Jan 1, 2012 Dec 31, 2012 10-K 2014-03-03
2011 $84.3M +$52.9M +168% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-03
2010 $31.4M Jan 1, 2010 Dec 31, 2010 10-K 2013-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.